title: Interaction study between rtPA and bevacizumab.
authors.forename: Céline
authors.initials: C
authors.lastname: Faure
authors.forename: Richard
authors.initials: R
authors.lastname: Macrez
authors.forename: Denis
authors.initials: D
authors.lastname: Vivien
authors.forename: José-Alain
authors.initials: JA
authors.lastname: Sahel
authors.forename: Sébastien
authors.initials: S
authors.lastname: Bonnel
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000378:metabolism*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D012166:Retinal Hemorrhage / Q000517:prevention & control; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004338:Drug Combinations; D000068258:Bevacizumab; D010959:Tissue Plasminogen Activator